Related Experiment Videos

Suppression of c-myc and c-myb expression in myeloid cell lines treated with recombinant tumor necrosis factor-alpha

J Schachner1, M Blick, E Freireich

  • 1Department of Hematology, M. D. Anderson Hospital and Tumor Institute, Houston, TX 77030.

Leukemia
|November 1, 1988
PubMed

Insights

Tumor necrosis factors (TNFs) reduce proliferation in some leukemia cells by decreasing expression of the c-myc and c-myb proto-oncogenes. This finding links TNF

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Proto-oncogenes like c-myc and c-myb regulate cell growth.
  • Tumor necrosis factors (TNFs) are cytokines with anti-cancer effects.
  • Previous studies showed recombinant TNFs (rTNFs) inhibit certain leukemia cell lines.

Purpose of the Study:

  • Investigate the role of c-myc and c-myb proto-oncogenes in TNF-induced antiproliferation.
  • Examine the expression of c-myc and c-myb in leukemia cells treated with rTNF-alpha.

Main Methods:

  • Assessed c-myc and c-myb gene expression in HL-60, KBM3, KBM5, and K562 cell lines.
  • Incubated cell lines with rTNF-alpha and measured changes in proto-oncogene expression over 24 hours.

Main Results:

  • c-myc and c-myb expression was initially high in all tested cell lines.
  • Sensitive cell lines (HL-60, KBM5, KBM3) showed rapid decreases in c-myc and c-myb expression after rTNF-alpha treatment.
  • Insensitive K562 cells displayed no significant change in c-myc or c-myb expression.

Conclusions:

  • Down-regulation of c-myc and c-myb expression is associated with the antiproliferative effect of rTNF-alpha.
  • Proto-oncogene regulation is a key mechanism in TNF-mediated cancer cell growth inhibition.

Related Concept Videos